ES2321858T3 - Compuestos de imidazo(1,2-a)piridina, composiciones, usos y metodos relacionados. - Google Patents

Compuestos de imidazo(1,2-a)piridina, composiciones, usos y metodos relacionados. Download PDF

Info

Publication number
ES2321858T3
ES2321858T3 ES05808135T ES05808135T ES2321858T3 ES 2321858 T3 ES2321858 T3 ES 2321858T3 ES 05808135 T ES05808135 T ES 05808135T ES 05808135 T ES05808135 T ES 05808135T ES 2321858 T3 ES2321858 T3 ES 2321858T3
Authority
ES
Spain
Prior art keywords
alkyl
substituted
methyl
imidazo
tolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05808135T
Other languages
English (en)
Spanish (es)
Inventor
Jose Luis Falco
Albert Palomer
Antonio Guglietta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrer Internacional SA
Original Assignee
Ferrer Internacional SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Internacional SA filed Critical Ferrer Internacional SA
Application granted granted Critical
Publication of ES2321858T3 publication Critical patent/ES2321858T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES05808135T 2004-11-11 2005-11-04 Compuestos de imidazo(1,2-a)piridina, composiciones, usos y metodos relacionados. Expired - Lifetime ES2321858T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105698 2004-11-11
EP04105698 2004-11-11

Publications (1)

Publication Number Publication Date
ES2321858T3 true ES2321858T3 (es) 2009-06-12

Family

ID=34929843

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05808135T Expired - Lifetime ES2321858T3 (es) 2004-11-11 2005-11-04 Compuestos de imidazo(1,2-a)piridina, composiciones, usos y metodos relacionados.

Country Status (24)

Country Link
US (1) US20080200473A1 (https=)
EP (1) EP1814880B1 (https=)
JP (1) JP2008519805A (https=)
KR (1) KR20070084026A (https=)
CN (1) CN101065377B (https=)
AR (1) AR051626A1 (https=)
AT (1) ATE421962T1 (https=)
AU (1) AU2005303811A1 (https=)
BR (1) BRPI0517796A (https=)
CA (1) CA2585315A1 (https=)
DE (1) DE602005012598D1 (https=)
DK (1) DK1814880T3 (https=)
ES (1) ES2321858T3 (https=)
IL (1) IL182963A0 (https=)
MX (1) MX2007005611A (https=)
NO (1) NO20072831L (https=)
PA (1) PA8652101A1 (https=)
PE (1) PE20060967A1 (https=)
PL (1) PL1814880T3 (https=)
PT (1) PT1814880E (https=)
RU (1) RU2007121864A (https=)
TW (1) TWI357412B (https=)
UY (1) UY29204A1 (https=)
WO (1) WO2006051063A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2477604A1 (en) 2002-03-13 2003-09-25 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
WO2006084033A1 (en) 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
EP1845098A1 (en) * 2006-03-29 2007-10-17 Ferrer Internacional, S.A. Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands
AU2007267183B2 (en) * 2006-05-31 2011-10-20 F. Hoffmann-La Roche Ag Aryl-4-ethynyl-isoxazole derivatives
CN101528226B (zh) * 2006-08-24 2012-01-11 澳大利亚核科学技术组织 靶向外周苯二氮卓受体的氟化配体
JP5607025B2 (ja) 2008-04-21 2014-10-15 シグナム バイオサイエンシーズ， インコーポレイテッド 化合物、組成物およびそれらを作製する方法
CA2724842A1 (en) * 2008-05-19 2009-11-26 Sunovion Pharmaceuticals Inc. Imidazo[1,2-a]pyridine compounds
US10478438B2 (en) 2008-10-16 2019-11-19 David Reed Helton Treatment of organophosphate exposure with ocinaplon
US20120010188A1 (en) * 2008-12-04 2012-01-12 Promimagen Ltd. Imidazopyridine Compounds
EP2496578A4 (en) 2009-11-05 2013-08-21 Univ Notre Dame Du Lac IMIDAZO [1,2-A] PYRIDINE COMPOUNDS, THEIR SYNTHESIS AND METHODS OF USE THEREOF
TW201225957A (en) 2010-09-17 2012-07-01 Taisho Pharmaceutical Co Ltd Glycine transporter inhibitor
KR20180053386A (ko) 2015-09-17 2018-05-21 마빈 제이. 밀러 마이코박테리아 감염에 대해 유용한 벤질 아민-함유 헤테로사이클릭 화합물 및 조성물
WO2017087885A1 (en) 2015-11-19 2017-05-26 Dana-Farber Cancer Institute, Inc. Methods of identifying compounds that interfere with erg-driven misguidance of baf complexes in tmprss2-erg driven prostate cancers
CN106906486B (zh) * 2017-02-22 2018-12-11 华南理工大学 3-溴-2-苯基-咪唑并[1,2-α]吡啶类衍生物的电化学合成方法
WO2019152437A1 (en) 2018-01-30 2019-08-08 Foghorn Therapeutics Inc. Compounds and uses thereof
WO2020081588A1 (en) 2018-10-17 2020-04-23 Dana-Farber Cancer Institute, Inc. Swi/snf family chromatin remodeling complexes and uses thereof
US12384776B2 (en) 2019-01-29 2025-08-12 Foghorn Therapeutics Inc. Compounds and uses thereof
WO2020160100A1 (en) 2019-01-29 2020-08-06 Foghorn Therapeutics Inc. Compounds and uses thereof
US20230121497A1 (en) * 2020-01-29 2023-04-20 Foghorn Therapeutics Inc. Compounds and uses thereof
CA3167275A1 (en) 2020-01-29 2021-08-05 Foghorn Therapeutics Inc. Compounds and uses thereof
US12383555B2 (en) 2020-05-20 2025-08-12 Foghorn Therapeutics Inc. Methods of treating cancers
JP2024509268A (ja) 2021-03-09 2024-02-29 フォグホーン セラピューティクス インコーポレイテッド 結晶形、それらを含有する組成物、及びそれらの使用方法
CN118515663A (zh) * 2023-04-24 2024-08-20 上海赛默罗生物科技有限公司 咪唑并吡啶或咪唑并吡嗪类化合物、其制备方法、药物组合物和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2568880B1 (fr) * 1984-08-07 1986-12-12 Synthelabo Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
FR2593818B1 (fr) * 1986-02-05 1988-04-29 Synthelabo Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
FR2593181B1 (fr) * 1986-01-22 1988-04-01 Synthelabo Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
ATE62687T1 (de) * 1986-01-22 1991-05-15 Synthelabo Acylaminomethylimidazo(1,2-a>pyrimidinderivate, ihre herstellung und therapeutische verwendung.
US20040204443A1 (en) * 2003-01-27 2004-10-14 Arthur Zaks Method for inducing pain relief using imidazo[1,2-a]pyridine derivatives

Also Published As

Publication number Publication date
EP1814880A1 (en) 2007-08-08
AR051626A1 (es) 2007-01-24
CN101065377B (zh) 2011-07-27
PA8652101A1 (es) 2006-10-13
UY29204A1 (es) 2006-01-31
PE20060967A1 (es) 2006-09-20
CA2585315A1 (en) 2006-05-18
MX2007005611A (es) 2007-07-11
EP1814880B1 (en) 2009-01-28
DE602005012598D1 (de) 2009-03-19
TW200624432A (en) 2006-07-16
PL1814880T3 (pl) 2009-07-31
ATE421962T1 (de) 2009-02-15
IL182963A0 (en) 2007-08-19
WO2006051063A1 (en) 2006-05-18
RU2007121864A (ru) 2008-12-20
BRPI0517796A (pt) 2008-10-28
PT1814880E (pt) 2009-04-23
TWI357412B (en) 2012-02-01
AU2005303811A1 (en) 2006-05-18
CN101065377A (zh) 2007-10-31
US20080200473A1 (en) 2008-08-21
KR20070084026A (ko) 2007-08-24
JP2008519805A (ja) 2008-06-12
DK1814880T3 (da) 2009-05-18
NO20072831L (no) 2007-08-01

Similar Documents

Publication Publication Date Title
ES2321858T3 (es) Compuestos de imidazo(1,2-a)piridina, composiciones, usos y metodos relacionados.
JP7677983B2 (ja) Ｐｇｄｈ阻害剤、およびその作製と使用の方法
US6492358B2 (en) β-carboline derivatives useful as inhibitors of phosphodiesterase
ES2291628T3 (es) Compuestos triciclicos a base de tiofeno y composiciones farmaceuticas que comprenden dichos compuestos.
ES2290782T3 (es) Derivados de (3-oxo-3,4-dihidro-quinoxalin-2-il-amino)-benzamida y compuestos aferentes como inhibidores de la glucogeno fosforilasa en el tratamiento de la diabetes y de la obesidad.
ES2230316T3 (es) Derivados de pirrolopiridinona sustituidos utiles como inhibidores de la fosfodiesterasa.
AU2004293416B2 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease
IL290154B2 (en) Benzopyrazole compounds and their analogs
BRPI0307351B1 (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
AU2004272104A1 (en) Fused ring heterocycles as potassium channel modulators
WO2024206339A1 (en) Quinolinone amide compounds and uses thereof
CN108530444A (zh) 一种新型nampt和ido双重抑制剂及其制备方法和医药用途
CA3195859A1 (en) Inhaled formulations of pgdh inhibitors and methods of use thereof
WO2024206345A1 (en) Quinazoline dione compounds and uses thereof
JP4917428B2 (ja) ２−置換フェニル−５，７−ジアルキル−３，７−ジヒドロピロロ［２，３−ｄ］ピリミジン−４−オン誘導体、その製法およびその医薬用途
ES2654399T3 (es) Derivados de imidazol aza-bicíclicos sustituidos útiles como moduladores de receptores TRPM8
EP3863631A1 (en) Pyrimidine and pyrazine hdac1,2 inhibitors
ES2212339T3 (es) Derivados de piperacina activos en el tracto urinario inferior.
ES2222813B1 (es) N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
US20040116440A1 (en) Bombesin receptor antagonists
ES2327278T3 (es) Hidrazidas del acido imidazo(1,2-a)piridin-3-il-acetico, procesos, usos y composiciones.
ES2246916T3 (es) Derivados de bencimidazol sustituidos con carboxamida, procedimiento para su preparacion y su empleo como inhibidores de triptasa.
ES2222814B1 (es) 3-nitro-pirazolo(1,5-a)pirimidinas 7-sustituidas y composiciones y metodos relacionados.
WO2025207622A1 (en) Quinolinone, benzoxazinone, and quinoline compounds and uses thereof
CN103827104A (zh) 双碳环和三碳环乙炔基衍生物及其应用